Style | Citing Format |
---|---|
MLA | Okhovat AA, et al.. "Evaluation of Quality of Life in Patients With Chronic Inflammatory Demyelinating Polyneuropathy in Iran." Journal of Clinical Neuromuscular Disease, vol. 21, no. 2, 2019, pp. 77-83. |
APA | Okhovat AA, Gholamalizadeh S, Nafissi S, Fatehi F (2019). Evaluation of Quality of Life in Patients With Chronic Inflammatory Demyelinating Polyneuropathy in Iran. Journal of Clinical Neuromuscular Disease, 21(2), 77-83. |
Chicago | Okhovat AA, Gholamalizadeh S, Nafissi S, Fatehi F. "Evaluation of Quality of Life in Patients With Chronic Inflammatory Demyelinating Polyneuropathy in Iran." Journal of Clinical Neuromuscular Disease 21, no. 2 (2019): 77-83. |
Harvard | Okhovat AA et al. (2019) 'Evaluation of Quality of Life in Patients With Chronic Inflammatory Demyelinating Polyneuropathy in Iran', Journal of Clinical Neuromuscular Disease, 21(2), pp. 77-83. |
Vancouver | Okhovat AA, Gholamalizadeh S, Nafissi S, Fatehi F. Evaluation of Quality of Life in Patients With Chronic Inflammatory Demyelinating Polyneuropathy in Iran. Journal of Clinical Neuromuscular Disease. 2019;21(2):77-83. |
BibTex | @article{ author = {Okhovat AA and Gholamalizadeh S and Nafissi S and Fatehi F}, title = {Evaluation of Quality of Life in Patients With Chronic Inflammatory Demyelinating Polyneuropathy in Iran}, journal = {Journal of Clinical Neuromuscular Disease}, volume = {21}, number = {2}, pages = {77-83}, year = {2019} } |
RIS | TY - JOUR AU - Okhovat AA AU - Gholamalizadeh S AU - Nafissi S AU - Fatehi F TI - Evaluation of Quality of Life in Patients With Chronic Inflammatory Demyelinating Polyneuropathy in Iran JO - Journal of Clinical Neuromuscular Disease VL - 21 IS - 2 SP - 77 EP - 83 PY - 2019 ER - |